Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Deloitte
Accenture
Harvard Business School
AstraZeneca
Chinese Patent Office
US Department of Justice
Citi
Healthtrust

Generated: August 17, 2018

DrugPatentWatch Database Preview

Fougera Pharms Inc Company Profile

« Back to Dashboard

What is the competitive landscape for FOUGERA PHARMS INC, and when can generic versions of FOUGERA PHARMS INC drugs launch?

FOUGERA PHARMS INC has twenty-eight approved drugs.

There are three US patents protecting FOUGERA PHARMS INC drugs.

There are forty-two patent family members on FOUGERA PHARMS INC drugs in twenty countries and twenty-one supplementary protection certificates in eleven countries.

Summary for Fougera Pharms Inc
International Patents:42
US Patents:3
Tradenames:15
Ingredients:15
NDAs:28

Drugs and US Patents for Fougera Pharms Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms Inc HYDROCORTISONE hydrocortisone CREAM;TOPICAL 089414-001 Dec 16, 1986 AT RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial
Fougera Pharms Inc HYDROCORTISONE hydrocortisone OINTMENT;TOPICAL 081203-001 May 28, 1993 AT RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial
Fougera Pharms Inc FLUOCINONIDE fluocinonide CREAM;TOPICAL 200735-001 Jul 14, 2014 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Fougera Pharms Inc TACROLIMUS tacrolimus OINTMENT;TOPICAL 200744-001 Sep 9, 2014 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Fougera Pharms Inc FLUOCINOLONE ACETONIDE fluocinolone acetonide SOLUTION;TOPICAL 088167-001 Dec 16, 1982 AT RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Fougera Pharms Inc LIDOCAINE lidocaine OINTMENT;TOPICAL 080198-001 Approved Prior to Jan 1, 1982 AT RX No Yes ➤ Try a Free Trial ➤ Try a Free Trial
Fougera Pharms Inc BETAMETHASONE VALERATE betamethasone valerate CREAM;TOPICAL 018861-001 Aug 31, 1983 AB RX Yes Yes ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Non-Orange Book US Patents for Fougera Pharms Inc

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
5,968,973 Method for treating hyperplasia ➤ Try a Free Trial
6,197,808 Methods for treating hyperplasia ➤ Try a Free Trial
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Fougera Pharms Inc Drugs

Country Document Number Estimated Expiration
Russian Federation 2004118667 ➤ Try a Free Trial
Germany 122009000072 ➤ Try a Free Trial
South Korea 100956369 ➤ Try a Free Trial
Brazil PI0214256 ➤ Try a Free Trial
Hong Kong 1073788 ➤ Try a Free Trial
Portugal 1448186 ➤ Try a Free Trial
Japan 3213557 ➤ Try a Free Trial
Country Document Number Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Supplementary Protection Certificates for Fougera Pharms Inc Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
2012 00040 Denmark ➤ Try a Free Trial PRODUCT NAME: EN BLANDING AF CATECHINER ISOLERET FRA ET EKSTRAKT AF GROEN TE (CAMELLIA SINENSIS (L.) O. KUNTTZE) , HERUNDER (-)-EPIGALLOCATECHINGALLAT; NAT. REG. NO/DATE: 49803 (DK) 20120702; FIRST REG. NO/DATE: DE 73486.00.00 20090831
1304992/01 Switzerland ➤ Try a Free Trial PRODUCT NAME: CLINDAMYCINI PHOSPHAS ET TRETINOINUM; REGISTRATION NO/DATE: SWISSMEDIC 62513 28.03.2014
00550 Netherlands ➤ Try a Free Trial PRODUCT NAME: MENGSEL VAN CATECHOLEN GEISOLEERD UIT EEN EXTRACT VAN GROENE THEE, CAMELLIA SINENSIS, L. O. KUNTZE MET ISOPROPYLMYRISTAAT; NATL. REGISTRATION NO/DATE: RVG 110904 20120920; FIRST REGISTRATION: DE 73486.00.00 20090831
C/GB15/042 United Kingdom ➤ Try a Free Trial PRODUCT NAME: DRY EXTRACT FROM CAMELLIA SINENSIS (L.) O.KUNTZE FOLIUM (GREEN TEA LEAVES) CORRESPONDING TO (-)-EPIGALLOCATECHIN GALLATE; REGISTERED: DE 73486.00.00 20090831; UK PL39972/0003 20150324
0550 Netherlands ➤ Try a Free Trial PRODUCT NAME: DROOG EXTRACT VAN GROENE THEE (CAMELLIA SINENSIS (L.) O.KUNZE FOLIUM) WATERIG (24-56:1) WAARVAN 100 MG OVEREENKOMT MET : 55-72 MG VAN (-)- EPIGALLOCATECHINEGALLAAT. EERSTE EXTRACTIEMIDDEL: WATER; NATIONAL REGISTRATION NO/DATE: RVG 110904 20120920; FIRST REGISTRATION: DE 73486.00.00 20090831
C0038 France ➤ Try a Free Trial PRODUCT NAME: ACYCLOVIR ET HYDROCORTISONE; NAT. REGISTRATION NO/DATE: NL 36 826 20100420; FIRST REGISTRATION: SK - 2108/08467-R 20091026
90030-4 Sweden ➤ Try a Free Trial PRODUCT NAME: TORRT EXTRAKT AV CAMELLIA SINENSIS (L.) O. KUNTZE, FOLIUM; NAT. REG. NO/DATE: 47136 20120405; FIRST REG.: DE 73486.00.00 20090831
Supplementary Protection Certificate SPC Country SPC Expiration SPC Description

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Cipla
Chinese Patent Office
Queensland Health
Farmers Insurance
UBS
Mallinckrodt
AstraZeneca
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.